2018 Cholesterol Guidelines: Key Topics in Primary Prevention.

{"article_title":"2018 Cholesterol Guidelines: Key Topics in Primary Prevention.","author":"Clark D 3rd, Virani SS","journal_title":"Current atherosclerosis reports","issn":"1534-6242","isbn":"","publication_date":"2019-03-16","volume":"21","issue":"5","first_page":"17","page_count":"","accession_number":"30877397","doi":"","publisher":"Springer","doctype":"Journal Article","subjects":"United States; Atherosclerosis prevention & control; Cholesterol blood; Primary Prevention standards; Adult; Aged; Anticholesteremic Agents therapeutic use; Atherosclerosis drug therapy; Healthy Lifestyle; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use; Middle Aged; Risk Assessment; Risk Factors; United States; Young Adult","interest_area":["Cardiology"," Internal Medicine"],"abstract":"Purpose of Review: The 2018 American College of Cardiology (ACC) and American Heart Association (AHA) cholesterol guidelines are a comprehensive update providing recommendations for management of patients with high blood cholesterol based on the best available evidence. This review highlights key topics clinicians need to know for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) based on the 2018 ACC\/AHA cholesterol guidelines. Recent Findings: The guidelines include a broad framework for risk estimation and management for primary prevention of ASCVD. Additional tools to refine risk assessment and guide management in primary prevention are outlined, including the use of risk-enhancing factors and coronary artery calcium score measurement. Lifestyle modification, appropriate risk assessment, and the use of proven pharmacologic therapies are essential for effective primary prevention as outlined in the 2018 ACC\/AHA cholesterol guidelines.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=30877397","isPdfLink":true,"isSAML":false,"an":"30877397","number_other":"","type_pub":"","issn_electronic":"1534-6242","languages":"English","language":"eng","date_entry":"","date_update":"","titleSource":"Current atherosclerosis reports [Curr Atheroscler Rep] 2019 Mar 16; Vol. 21 (5), pp. 17. Date of Electronic Publication: 2019 Mar 16.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2019-03-16","description":"Purpose of Review: The 2018 American College of Cardiology (ACC) and American Heart Association (AHA) cholesterol guidelines are a comprehensive update providing recommendations for management of patients with high blood cholesterol based on the best available evidence. This review highlights key topics clinicians need to know for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) based on the 2018 ACC\/AHA cholesterol guidelines.<br \/>Recent Findings: The guidelines include a broad framework for risk estimation and management for primary prevention of ASCVD. Additional tools to refine risk assessment and guide management in primary prevention are outlined, including the use of risk-enhancing factors and coronary artery calcium score measurement. Lifestyle modification, appropriate risk assessment, and the use of proven pharmacologic therapies are essential for effective primary prevention as outlined in the 2018 ACC\/AHA cholesterol guidelines.","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=30877397&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"Clark D 3rd, Virani SS","header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"30877397","RelevancyScore":"845","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"845.356872558594"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=30877397&authtype=shib&custid=ns346513&group=main&profile=eds","physicalDescription":{"Pagination":{"StartPage":"17"}},"additionalInfo":{"Authored_By":"Clark D 3rd, Virani SS","Journal_Info":"Publisher: Springer Country of Publication: United States NLM ID: 100897685 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6242 (Electronic) Linking ISSN: 15233804 NLM ISO Abbreviation: Curr Atheroscler Rep Subsets: MEDLINE","Publication_Type":"Journal Article; Practice Guideline; Review","Published_Date":"2019-03-16","Source":"Current atherosclerosis reports [Curr Atheroscler Rep] 2019 Mar 16; Vol. 21 (5), pp. 17. Date of Electronic Publication: 2019 Mar 16.","Languages":"English","Electronic_ISSN":"1534-6242","MeSH_Terms":"Atherosclerosis\/*prevention & control , Cholesterol\/*blood , Primary Prevention\/*standards, Adult ; Aged ; Anticholesteremic Agents\/therapeutic use ; Atherosclerosis\/drug therapy ; Healthy Lifestyle ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors\/therapeutic use ; Middle Aged ; Risk Assessment ; Risk Factors ; United States ; Young Adult","Subjects":"Adult, Aged, Anticholesteremic Agents therapeutic use, Atherosclerosis drug therapy, Healthy Lifestyle, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Middle Aged, Risk Assessment, Risk Factors, United States, Young Adult, Atherosclerosis prevention & control, Cholesterol blood, Primary Prevention standards","Title_Abbreviations":"Current atherosclerosis reports","Volume":"21"}}